VOYA INVESTMENT MANAGEMENT LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 157 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.4%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$51,000
-40.0%
78,0950.0%0.00%
Q4 2021$85,000
-46.5%
78,095
-10.9%
0.00%
Q3 2021$159,000
-31.2%
87,6310.0%0.00%
Q2 2021$231,000
-32.8%
87,631
-8.3%
0.00%
-100.0%
Q1 2021$344,000
+47.6%
95,549
+3.4%
0.00%
Q4 2020$233,000
+23.9%
92,419
+23.8%
0.00%
Q3 2020$188,000
-23.3%
74,6470.0%0.00%
-100.0%
Q2 2020$245,000
+11.4%
74,647
-16.9%
0.00%0.0%
Q1 2020$220,000
-39.9%
89,878
+15.9%
0.00%0.0%
Q4 2019$366,000
+36.6%
77,544
+23.7%
0.00%0.0%
Q3 2019$268,000
-26.8%
62,7100.0%0.00%0.0%
Q2 2019$366,000
+71.0%
62,710
+12.7%
0.00%
Q1 2019$214,000
+105.8%
55,6210.0%0.00%
Q4 2018$104,000
-41.6%
55,6210.0%0.00%
Q3 2018$178,000
+6.0%
55,6210.0%0.00%
Q2 2018$168,000
-29.4%
55,621
-8.5%
0.00%
-100.0%
Q1 2018$238,000
-5.6%
60,7820.0%0.00%0.0%
Q4 2017$252,000
-32.4%
60,7820.0%0.00%0.0%
Q3 2017$373,000
-1.3%
60,7820.0%0.00%0.0%
Q2 2017$378,000
+19.6%
60,782
+21.9%
0.00%0.0%
Q1 2017$316,000
+18.4%
49,8690.0%0.00%0.0%
Q4 2016$267,000
-5.0%
49,8690.0%0.00%0.0%
Q3 2016$281,000
+2.6%
49,8690.0%0.00%0.0%
Q2 2016$274,000
-25.9%
49,8690.0%0.00%0.0%
Q1 2016$370,000
-10.6%
49,8690.0%0.00%0.0%
Q4 2015$414,000
-7.8%
49,8690.0%0.00%0.0%
Q3 2015$449,000
-33.8%
49,869
-11.7%
0.00%
-50.0%
Q2 2015$678,000
+23.7%
56,487
+11.0%
0.00%
+100.0%
Q1 2015$548,000
+112.4%
50,8860.0%0.00%0.0%
Q4 2014$258,000
+92.5%
50,8860.0%0.00%
Q3 2014$134,000
-34.6%
50,8860.0%0.00%
Q2 2014$205,000
-12.0%
50,8860.0%0.00%
-100.0%
Q1 2014$233,000
+5.4%
50,8860.0%0.00%0.0%
Q4 2013$221,00050,8860.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2015
NameSharesValueWeighting ↓
Third Security, LLC 17,815,708$47,033,0002.93%
Essex Woodlands Management, Inc. 2,764,908$7,130,0002.60%
Belmont Global Advisors, Inc. 973,000$2,569,0002.01%
Belmont Global Advisors, Inc. 135,700$358,0000.28%
MSD Partners, L.P. 2,750,000$7,260,0000.22%
SFMG, LLC 99,850$264,0000.08%
Rotella Capital Management, Inc. 11,090$29,0000.03%
WESTPORT RESOURCES MANAGEMENT INC 33,500$88,0000.02%
SMITH ASSET MANAGEMENT GROUP LP 236,590$625,0000.02%
FRANKLIN STREET ADVISORS INC /NC 41,150$109,0000.02%
View complete list of ZIOPHARM ONCOLOGY INC shareholders